Patents by Inventor Shinta CHENG

Shinta CHENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230372300
    Abstract: The present disclosure relates to improved methods of treatment with nirogacestat.
    Type: Application
    Filed: May 19, 2023
    Publication date: November 23, 2023
    Inventors: Allison Lim, Shinta Cheng, Todd Webster Shearer, Rex Williams, Kristin Patterson
  • Publication number: 20230372301
    Abstract: The present disclosure relates to improved methods of treatment with nirogacestat.
    Type: Application
    Filed: May 19, 2023
    Publication date: November 23, 2023
    Inventors: Allison Lim, Shinta Cheng, Todd Webster Shearer, Rex Williams, Kristin Patterson
  • Publication number: 20230241028
    Abstract: The present disclosure relates to methods for treating ovarian cancer comprising nirogacestat or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 1, 2023
    Publication date: August 3, 2023
    Inventors: Shinta CHENG, Todd SHEARER
  • Publication number: 20230087828
    Abstract: The present disclosure relates to: a) solid state forms of hydrobromide salts of Compound 1; b) pharmaceutical compositions comprising one or more solid state forms of hydrobromide salts of Compound 1, and, optionally, a pharmaceutically acceptable carrier; c) methods of treating tumors or cancers by administering one or more solid state forms of hydrobromide salts of Compound 1 to a subject in need thereof, and d) methods for the preparation of solid state forms of Compound 1.
    Type: Application
    Filed: October 24, 2022
    Publication date: March 23, 2023
    Applicant: SpringWorks Therapeutics, Inc.
    Inventors: Shinta CHENG, Todd Webster SHEARER, Rex WILLIAMS, Kristin PATTERSON
  • Publication number: 20230049311
    Abstract: The present disclosure relates to: a) solid state forms of hydrobromide salts of Compound 1; b) pharmaceutical compositions comprising one or more solid state forms of hydrobromide salts of Compound 1, and, optionally, a pharmaceutically acceptable carrier; c) methods of treating tumors or cancers by administering one or more solid state forms of hydrobromide salts of Compound 1 to a subject in need thereof; and d) methods for the preparation of solid state forms of Compound 1.
    Type: Application
    Filed: October 6, 2022
    Publication date: February 16, 2023
    Applicant: SpringWorks Therapeutics, Inc.
    Inventors: Shinta CHENG, Todd Webster SHEARER, Rex WILLIAMS, Kristin PATTERSON
  • Publication number: 20210000953
    Abstract: This disclosure provides a method for treating glioma in a subject comprising administering to the subject an anti-Programmed Death-1 (PD-1) antibody. In some embodiments, this invention relates to methods for treating glioma in a subject comprising administering to the subject a combination of an anti-cancer agent which is an anti-Programmed Death-1 (PD-1) antibody and another anti-cancer agent such as an anti-Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) antibody.
    Type: Application
    Filed: July 20, 2020
    Publication date: January 7, 2021
    Applicant: Bristol-Myers Squibb Company
    Inventors: Vladimir CORIC, Shinta CHENG
  • Publication number: 20180133313
    Abstract: This disclosure provides a method for treating glioma in a subject comprising administering to the subject an anti-Programmed Death-1 (PD-1) antibody. In some embodiments, this invention relates to methods for treating glioma in a subject comprising administering to the subject a combination of an anti-cancer agent which is an anti-Programmed Death-1 (PD-1) anti-body and another anti-cancer agent such as an anti-Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) antibody.
    Type: Application
    Filed: December 16, 2015
    Publication date: May 17, 2018
    Applicant: Bristol-Myers Squibb Company
    Inventors: Vladimir CORIC, Shinta CHENG